Skip to content
Resources > Reports

The 2025 State of AI for Business and Finance

Over the past few years, generative AI has gone from hypothetical to reality. In 2025, a year marked by hype and hesitation, the teams seeing the biggest gains aren’t chasing shiny tools — they are quietly transforming how work gets done. According to The 2025 State of AI for Business and Finance, organizations adopting workflow-integrated, expert-driven AI are seeing measurable gains in efficiency and insight generation. By embedding AI into real workflows, they’re unlocking new levels of productivity, sharper insights, and faster decisions.

The 2025 State of AI for Business and Finance highlights:

  • How genAI use is extending beyond efficiency, supporting more informed analysis and timely decision-making
  • The biggest challenges organizations face when integrating AI into strategic workflows
  • The road ahead for AI adoption and integration, and more on what’s next, including the build vs. buy debate

Featuring the perspectives of 300 professionals, mostly decision-makers on genAI usage in their firms, this report offers an up-to-date view on how AI is driving both opportunity and disruption across areas like consulting, corporate strategy, competitive intelligence, asset management, and investment banking.

Download The 2025 State of AI for Business and Finance to get a clear view of how AI-driven intelligence is transforming productivity, insight, and competitive advantage.

Explore more

Enterprise Software: Assessing AI Adoption Trends

Generative AI is moving from isolated pilots to full-scale deployments, with adoption accelerating in areas like software development and IT service management.
Title slide: Enterprise Software: Assessing AI Adoption Trends, by Michelle Brophy and Sean Carmichael, featuring a computer illustration and AI logo.

From Promise to Performance: How AI Will Evolve in 2026

2025 was the year generative AI grew up, shifting from isolated experiments to integrated systems. What also emerged was a clearer picture of how AI will continue to mature in 2026.
Title slide: From Promise to Performance: How AI Will Evolve in 2026 by Sarah Hoffman, Director of AI Thought Leadership, with abstract tech graphics.

Most-Favored-Nation Policy: Implications for European Drug Launches

The U.S. shift toward most-favored-nation (MFN) drug pricing is forcing pharmaceutical firms to rethink their pricing models and launch strategies in Europe.
U.S. Most-Favored-Nation Drug Pricing Policy: What Does It Mean for Europe? by Sara Mallatt and Sean Carmichael, with a stylized map of Europe.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.